Health TrialsbyHealthPanel

Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)

ConditionsHepatitis Autoimmune DiseasePrimary Biliary Cholangitis (PBC)Primary Sclerosing Cholangitis (PSC)Cholestatic Genetic Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAsociación Española para el Estudio del Hígado

About this trial

The purpose of the registry is to know the status of primary biliary colgantis, autoimmune hepatitis, primary sclerosing cholagitis and genetic cholestatic diseases in Spain.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with a confirmed diagnosis for PBC, HAI, PSC, genetic cholestatic disease

Disqualifiers

Refusal to sign the informed consent for the study

Trial population

Patients with a confirmed diagnosis for PBC, HAI, PSC or any genetic cholestasis

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Prevalence and characteristics of autoimmune and cholestatic liver disease in Spain

Evaluation of clinical characteristics of autoimmune and cholestatic liver diseases

Time frame
2025

Secondary outcomes

1

Development of liver-related events in autoimmune ahd cholestatic liver diseases

Time frame
2025
2

Treatment of autoimmune and cholestatic liver diseases in Spain

Time frame
2016-2030

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Asociación Española para el Estudio del Hígado

Lead sponsor

Source ClinicalTrials.gov
Apply now